NCT05472441 Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)
| NCT ID | NCT05472441 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ohio State University |
| Condition | Diabetes Mellitus, Type 2 |
| Study Type | INTERVENTIONAL |
| Enrollment | 568 participants |
| Start Date | 2023-02-06 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 568 participants in total. It began in 2023-02-06 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a pragmatic randomized controlled trial (pRCT) that aims to test the effect of produce provision, diabetes education, and community referrals on hemoglobin A1c levels in individuals with type 2 diabetes experiencing food insecurity.
Eligibility Criteria
Inclusion Criteria: * Type 2 Diabetes based on American Diabetes Association Criteria * Hemoglobin A1c ≥ 7.5% * Screen Positive on 2-item Food Security Screener Exclusion Criteria: * Unwilling to Attest to Release of Information to Mid-Ohio Food Collective
Contact & Investigator
Joshua Joseph, MD, MPH
PRINCIPAL INVESTIGATOR
Ohio State University
Frequently Asked Questions
Who can join the NCT05472441 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetes Mellitus, Type 2. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05472441 currently recruiting?
Yes, NCT05472441 is actively recruiting participants. Contact the research team at luiza.reopell@osumc.edu for enrollment information.
Where is the NCT05472441 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT05472441 clinical trial?
NCT05472441 is sponsored by Ohio State University. The principal investigator is Joshua Joseph, MD, MPH at Ohio State University. The trial plans to enroll 568 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.